Board of Directors
Co-founder and Director
Mr. Hoffmann is entirely dedicated to Network Immunology's systems approach to optimizing and protecting health by way of immuno-therapy. He co-founded Network Immunology in 2003 with Chief Scientist, Dr. Geoffrey Hoffmann.
Chairman and Chief Scientist
Dr. Hoffmann obtained his PhD (Dr. rer. nat.) in 1972 from the Technische Universität Braunschweig as a student of Professor Manfred Eigen for research done at the Max Planck Institut für Biophysikalische Chemie in Göttingen, Germany. He began his research on immune network theory in 1974 at that Institute.
Dr. Gorczynski works with Dr. Geoffrey Hoffmann on the development of AbstimX™. Dr. Gorczynski's primary interests and expertise are in adaptive immunity, the regulation of tumor growth/metastasis and the regulation of transplant rejection.
Dr. Willmer currently holds the position of Senior Medical Director, Head of Clinical Neurology, Global Research and Early Development, at EMD Serono in Boston, Massachusetts. He is responsible for early clinical development in neurodegenerative diseases.